Skip to main content

Table 2 Life expectancy and YLL analysis results for patients with lung cancer

From: Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea

Year (Standard error)

Patients with lung cancer

Control group

Years of life lost (YLL)

STa

eST b

eST b

Total (n = 2919)

2.48 (0.06)

4.53 (0.21)

14.51 (0.10)

9.99 (0.23)

Surgery (n = 426)

6.73 (0.13)

14.19 (0.91)

16.49 (0.22)

2.30 (0.94)

Surgery+CTx/RTx (n = 296)

5.09 (0.20)

8.51 (1.00)

17.25 (0.22)

8.74 (1.02)

CTx/RTx (n = 1405)

1.87 (0.06)

3.01 (0.20)

15.18 (0.13)

12.16 (0.24)

BSC (n = 792)

0.37 (0.01)

NA

NA

NA

  1. BSC best supportive care, CTx/RTx chemotherapy and/or radiation therapy, eST estimated survival time, ST survival time
  2. aActual survival time based on the real data from a 100-month follow-up period
  3. bEstimated survival time based on the actual survival time during the real follow-up period (100 months) and extrapolated life expectancy for the next 200 months